HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diclofenac sodium and spasmolytic drugs in the treatment of ureteral colic: a comparative study.

Abstract
Forty-nine patients with ureteral colic were included in this prospective double-blind study investigating the analgesic efficacy and side effects of a prostaglandin synthetase inhibitor Diclofenac sodium (Voltaren) versus a spasmolytic drug Tropenzilium bromide (Palerol). The analgesic efficacy and side effects of the calcium antagonist Nifedipine (Nidilat) applied sublingually in ureteral colic were also investigated. It was concluded that diclofenac sodium was more efficient for relieving pain due to acute ureteral obstruction and had fewer side effects than spasmolytic drugs. Nifedipine proved to have an analgesic effect equivalent to that of Tropenzilium bromide.
AuthorsI Başar, K Bircan, C Taşar, A Ergen, F Cakmak, D Remzi
JournalInternational urology and nephrology (Int Urol Nephrol) Vol. 23 Issue 3 Pg. 227-30 ( 1991) ISSN: 0301-1623 [Print] Netherlands
PMID1889968 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Analgesics
  • Drug Combinations
  • Parasympatholytics
  • Pyrazoles
  • Tropanes
  • Diclofenac
  • Dipyrone
  • Palerol
  • Nifedipine
Topics
  • Adult
  • Analgesics
  • Colic (drug therapy)
  • Diclofenac (therapeutic use)
  • Dipyrone (therapeutic use)
  • Double-Blind Method
  • Drug Combinations
  • Female
  • Humans
  • Male
  • Nifedipine (pharmacology, therapeutic use)
  • Parasympatholytics (therapeutic use)
  • Prospective Studies
  • Pyrazoles (therapeutic use)
  • Tropanes (therapeutic use)
  • Ureteral Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: